The high expression of Ki-67, MCM2, Cyclin A and PHH3 is also in correlation with high grade and triple negativity, therefore all tested marker seem to be potentially applicable to delineate a patient group with biologically aggressive breast tumors to be suitable to PST. Here, MCM2 is linked to breast neoplasm.